Refresh
Company Event • 18 Nov 2021 16:00 • Latest
Location:Japan
Call Conference regarding STN1011700 in the U.S.
Speakers
- Shigeo Taniuchi (President & CEO, Santen Pharmaceutical Co., Ltd.)
- Akio Kimura (Senior Corporate Officer, Global Product Supply, Santen Pharmaceutical Co., Ltd.)
- Satoshi Suzuki (Senior Corporate Officer, Head of Corporate Development Division, Santen Pharmaceutical Co., Ltd.)
- Kenji Morishima (Corporate Officer, Head of China Product Development Department, Santen Pharmaceutical Co., Ltd.)
- Peter Sallstig (Corporate Officer, Head of Product Development Division, Santen Pharmaceutical Co., Ltd.)
Analysts
- Fumiyoshi Sakai (Analyst, Credit Suisse Securities (Japan) Limited)
- Akinori Ueda (Analyst, Goldman Sachs Japan Co., Ltd.)
- Kazuaki Hashiguchi (Analyst, Daiwa Securities Co. Ltd.)
- Naomi Kumagai (Analyst, Mitsubishi UFJ Morgan Stanley Securities Co., Ltd.)
- Shohei Oda (Analyst, Morgan Stanley MUFG Securities Co., Ltd.)
Duration
- Presentation: 24 minutes
- Q&A: 24 minutes
Company Event • 09 Nov 2021 13:00
Location:Japan
Q2 FY2021 Financial Results
Speakers
- Shigeo Taniuchi (President & CEO, Santen Pharmaceutical Co., Ltd.)
- Kazuo Koshiji (Senior Corporate Officer of Corporate Administration, CFO, Head of Finance and Administration Division, Santen Pharmaceutical Co., Ltd.)
- Satoshi Suzuki (Senior Corporate Officer, Head of Corporate Development Division, Santen Pharmaceutical Co., Ltd.)
- Kenji Morishima (Corporate Officer, Head of China Product Development Department, Santen Pharmaceutical Co., Ltd.)
- Kaori Itagaki (Corporate Development Division, IR Group, General Manager, Santen Pharmaceutical Co., Ltd.)
Analysts
- Fumiyoshi Sakai (Analyst, Credit Suisse Securities (Japan) Limited)
- Akinori Ueda (Analyst, Goldman Sachs Japan Co., Ltd.)
- Hidemaru Yamaguchi (Analyst, Citigroup Global Markets Japan Inc.)
- Kazuaki Hashiguchi (Analyst, Daiwa Securities Co. Ltd.)
- Takashi Akahane (Analyst, Tokai Tokyo Research Institute Co., Ltd.)
- Shohei Oda (Analyst, Morgan Stanley MUFG Securities Co., Ltd.)
Company Event • 06 Aug 2021 16:30
Location:Japan
1Q FY 2021 Consolidated Performance
Speakers
- Satoshi Suzuki (Senior Corporate Officer, Head of Corporate Development Division, Santen Pharmaceutical Co., Ltd.)
- Kenji Morishima (Corporate Officer, Head of China Product Development Department, Santen Pharmaceutical Co., Ltd.)
- Shigeo Taniuchi (President & CEO, Santen Pharmaceutical Co., Ltd.)
- Kazuo Koshiji (Senior Corporate Officer of Corporate Administration, CFO, Head of Finance and Administration Division, Santen Pharmaceutical Co., Ltd.)
- Kaori Itagaki (Corporate Development Division, IR Group, General Manager, Santen Pharmaceutical Co., Ltd.)
Analysts
- Fumiyoshi Sakai (Analyst, Credit Suisse Securities (Japan) Limited)
- Akinori Ueda (Analyst, Goldman Sachs Japan Co., Ltd.)
- Hidemaru Yamaguchi (Analyst, Citigroup Global Markets Japan Inc.)
- Tatsuyuki Arai (Analyst, BofA Securities Japan Co., Ltd.)
- Shohei Oda (Analyst, Morgan Stanley MUFG Securities Co., Ltd.)
Duration
- Presentation: 22 minutes
- Q&A: 22 minutes
Company Event • 19 May 2021 14:30
Location:Japan
Mid-term plan presentation
Speakers
- Shigeo Taniuchi (President & Chief Executive Officer, Santen Pharmaceutical Co., Ltd.)
- Takeshi Ito (Director of the Board, Executive Corporate Officer, Head of Japan Business, Head of Japan Sales & Marketing Division, Santen Pharmaceutical Co., Ltd.)
- Kazuo Koshiji (Senior Corporate Officer, Corporate Administration, Chief Financial Officer (CFO), Head of Finance and Administration Division, Santen Pharmaceutical Co., Ltd.)
- Satoshi Suzuki (Senior Corporate Officer, Head of Corporate Development Division, Santen Pharmaceutical Co., Ltd.)
- Kenji Morishima (Corporate Officer, Head of China Product Development Department, Santen Pharmaceutical Co., Ltd.)
- Peter Sallstig (Corporate Officer, Head of Product Development Division, Santen Pharmaceutical Co., Ltd.)
- Takayuki Yamada (Corporate Officer, Head of China Business, Santen Pharmaceutical Co., Ltd.)
- Kaori Itagaki (Corporate Development Division, IR Group, General Manager, Santen Pharmaceutical Co., Ltd.)
- Hidaka (Corporate Communications Group, Santen Pharmaceutical Co., Ltd.)
Analysts
- Fumiyoshi Sakai (Analyst, Credit Suisse Securities (Japan) Limited)
- Akinori Ueda (Analyst, Goldman Sachs Japan Co., Ltd.)
- Hidemaru Yamaguchi (Analyst, Citigroup Global Markets Japan Inc.)
- Kazuaki Hashiguchi (Analyst, Daiwa Securities Co. Ltd.)
- Tatsuyuki Arai (Analyst, BofA Securities Japan Co., Ltd.)
- Shohei Oda (Analyst, Morgan Stanley MUFG Securities Co., Ltd.)
- Hyogo (Analyst, Mitsubishi UFJ Trust and Banking Corporation)
Duration
- Presentation: 44 minutes
- Q&A: 44 minutes
Company Event • 12 May 2021 13:00
Location:Japan
Investor Event on FY2020 Results
Speakers
- Shigeo Taniuchi (President & Chief Executive Officer, Santen Pharmaceutical Co., Ltd.)
- Kazuo Koshiji (Senior Corporate Officer, Corporate Administration, Chief Financial Officer (CFO), Head of Finance and Administration Division, Santen Pharmaceutical Co., Ltd.)
- Satoshi Suzuki (Senior Corporate Officer, Head of Corporate Development Division, Santen Pharmaceutical Co., Ltd.)
- Kenji Morishima (Corporate Officer, Head of China Product Development Department, Santen Pharmaceutical Co., Ltd.)
- Kaori Itagaki (Corporate Development Division, IR Group, General Manager, Santen Pharmaceutical Co., Ltd.)
Analysts
- Fumiyoshi Sakai (Analyst, Credit Suisse Securities (Japan) Limited)
- Akinori Ueda (Analyst, Goldman Sachs Japan Co., Ltd.)
- Kazuaki Hashiguchi (Analyst, Daiwa Securities Co. Ltd.)
- Takashi Akahane (Analyst, Tokai Tokyo Research Institute Co., Ltd.)
- Tatsuyuki Arai (Analyst, BofA Securities Japan Co., Ltd.)
- Shohei Oda (Analyst, Morgan Stanley MUFG Securities Co., Ltd.)
- Hidemaru Yamaguchi (Analyst, Citigroup Global Markets Japan Inc.)
Duration
- Presentation: 28 minutes
- Q&A: 28 minutes